Delayed lichenoid drug eruption associated with apremilast
Saved in:
| Main Authors: | Betty Hinderks-Davis, MD, Madilynn Hintz, MS3, Alisa L. Green, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512625000232 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Treatment of Ustekinumab-Associated Lichenoid Drug Eruption with Upadacitinib: A Case Report
by: Xia M, et al.
Published: (2025-04-01) -
Lichenoid dysplasia treated by apremilast - report of two cases and review of literature
by: Shiladitya Sil, et al.
Published: (2025-04-01) -
Assessing the Effect of Apremilast on Serum Leptin levels in Obese Patients with Psoriasis
by: Haitham Mohammed Saad, et al.
Published: (2024-12-01) -
Efficacy and Safety of Apremilast in Oncological Patients with Moderate-to-Severe Plaque Psoriasis: A 5 years Retrospective Observational Study
by: Lanna C, et al.
Published: (2025-05-01) -
Clinical experience with apremilast for psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2018-09-01)